Studies on the inhibitory effects of quercetin on the HL-60 leukemia cells

Biochemical Pharmacology

Volumn 54, Issue 9, 1997, Pages 1013-1018

  Kang, Tie Bang ^a   Liang, Nian Ci ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Flavonoids; Human HL 60 promyelocytic leukemia cell; Phosphoinositides; Protein kinase C; Quercetin; Tyrosine protein kinase

Indexed keywords

FLAVONOID; PHOSPHATIDYLINOSITIDE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; QUERCETIN;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; CULTURE MEDIUM; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DIVISION; HL-60 CELLS; HUMANS; PHOSPHATIDYLINOSITOLS; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; QUERCETIN;

EID: 0030712279     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00260-8     Document Type: Article

References (37)

1. Bjeldanes JF and Chang GF, Mutagenic activity of quercetin and related compounds. Science 197: 577-578, 1977.
2. Kim JH, Kim SH, Alfieri AA and Young CW, Quercetin, an inhibitor of lactate transport and a hyperthermic sensitizer of HeLa cells. Cancer Res 44: 102-106, 1984.
3. MacGregor JT, Genetic toxicology of dietary flavonoids. Prog Clin Biol Res 206: 33-43, 1986.
4. Soulinna E-M, Buchsbaum RN and Racker E, The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res 35: 1865-1872, 1975.
5. Wei Y-Q, Zhao X, Kariya Y, Fukata H, Teshigawara K and Uchida A, Induction of apoptosis by quercetin: Involvement of heat shock protein. Cancer Res 54: 4952-4957, 1994.
6. Markaverich BM, Roberts RR, Alejandro MA, Johnson GA, Middleditch BS and Clark JH, Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition. J Steroid Biochem 30: 71-78, 1988.
7. Scambia G, Ranelletti FO, Panici PB, Piantelli M, Bonanno G, De Vincenzo R, Ferrandina G, Rumi C, Larocca LM and Mancuso S, Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. Br J Cancer 62: 942-946, 1990.
8. Scambia G, Ranelletti FO, Benedetti Panici P, Piantelli M, Rumi C, Battaglia F, Larocca LM, Capelli A and Mancuso S, Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoids. Int J Cancer 46: 1112-1116, 1990.
9. Larocca LM, Piantelli M, Leone G, Sica S, Teofili L, Benedetti Panici P, Scambia G, Mancuso S, Capelli A and Ranelletti FO, Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: Growth inhibitory effect of oestrogen and flavonoids. Br J Haematol 75: 489-495, 1990.
10. Piantelli M, Rinelli A, Macri E, Maggiano N, Larocca LM, Scerrati M, Roselli R, Iacoangeli M, Scambia G, Capelli A and Ranelletti FO, Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Cancer 71: 193-198, 1993.
11. Hofmann J, Doppler W, Jakob A, Maly K, Posch L, Überall F and Grunicke HH, Enhancement of the antiproliferative effect of cis-diamminedichloroplatinum (II) and nitrogen mustard by inhibitors of protein kinase C. Int J Cancer 42: 382-388, 1988.
12. Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, Fujioka A, Nishino H and Aoike A, The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260: 10-13, 1990.
13. Hosokawa N, Hosokawa Y, Sakai T, Yoshida M, Marui N, Nishino H, Kawai K and Aoike A, Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-kDa protein in human colon cancer cells. Int J Cancer 45: 1119-1124, 1990.
14. 1 phase of the cell cycle. Cancer Res 52: 6676-6681, 1992.
15. Avila MA, Velasco JA, Cansado J and Notario V, Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res 54: 2424-2428, 1994.
16. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H and Aoike A, Genistein arrests cell cycle progression at G2-M. Cancer Res 53: 1329-1331, 1993.
17. cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity. Biochem Pharmacol 46: 1831-1840, 1993.
18. Nishizuka Y, Studies and prospectives of the protein kinase C family for cellular regulation. Cancer 63: 1892-1903, 1989.
19. Meek DW and Street AJ, Nuclear protein phosphorylation and growth control. Biochem J 287: 1-15, 1992.
20. Ullrich A and Schlessinger J, Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212, 1990.
21. Bolen JB, Signal transduction by the SRC family of tyrosine protein kinases in hemopoietic cells. Cell Growth Differ 2: 409-414, 1991.
22. Rana RS and Hokin LE, Role of phosphoinositides in transmembrane signaling. Physiol Rev 70: 115-164, 1990.
23. Stephens L, Molecules mediating signals. Biochem Soc Trans 23: 207-221, 1995.
24. Ferriola PC, Cody V and Middleton E Jr, Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure - activity relationships. Biochem Pharmacol 38: 1617-1624, 1989.
25. Kantengwa S and Polla BS, Flavonoids, but not protein kinase C inhibitors, prevent stress protein synthesis during erythrophagocytosis. Biochem Biophys Res Commun 180: 308-314, 1991.
26. Barret JM, Ernould AP, Ferry G, Genton A and Boutin JA, Integrated system for the screening of the specificity of protein kinase inhibitors. Biochem Pharmacol 46: 439-448, 1993.
27. Cunningham BD, Threadgill MD, Groundwater PW, Dale IL and Hickman JA, Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases. Anticancer Drug Des 7: 365-384, 1992.
28. Weber G, Singhal RL, Prajda N, Yeh YA, Look KY and Sledge GW, Regulation of signal transduction. Adv Enzyme Regul 35: 1-21, 1995.
29. Kong SK and Wang JH, Purification and characterization of a protein tyrosine kinase from bovine spleen. J Biol Chem 262: 2597-2603, 1987.
30. Kang T-B, Li Y-S and Liang N-C, Studies on activities of TPK and PKC from two nasopharyngeal carcinoma cell lines. J Cancer China, in press.
31. Krug E and Tashjian AH Jr, Time-dependent changes in protein kinase C distribution and disappearance in phorbol ester-treated human osteosarcoma cells. Cancer Res 47: 2243-2246, 1987.
32. Wu P and Liang N-C, Vincristine inhibits HL-60 cell proliferation by interfering with the metabolism of phosphoinositides. Chin Pharmacol Bull 9: 210-212, 1993.
33. Lapetina EG and Siess W, Measurement of inositol phospholipid turnover in platelets. Methods Enzymol 141: 176-193, 1987.
34. Rizzo MT and Weber G, 1-Phosphatidylinositol 4-kinase (EC 2.7.1.67): An enzyme linked with proliferation and malignancy. Cancer Res 54: 2611-2614, 1994.
35. Singhal RL, Prajda N, Yeh YA and Weber G, 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): A proliferation-and malignancy-linked signal transduction enzyme. Cancer Res 54: 5576-5578, 1994.
36. Prajda N, Singhal RL, Yeh YA, Olah E, Look KY and Weber G, Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin. Life Sci 56: 1587-1593, 1995.
37. Singhal RL, Yeh YA, Prajda N, Sledge GW and Weber G, Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun 208: 425-431, 1995.